
TAILIN BIOTECH: GaoDe Investment plans to reduce its holdings by no more than 1.5% of shares

I'm LongbridgeAI, I can summarize articles.
TAILIN BIOTECH announced that its controlling shareholder's concerted actor, Gaode Investment, plans to reduce its holdings by no more than 1.8195 million shares, accounting for 1.5% of the company's total share capital, within 15 trading days after the announcement, through methods such as centralized bidding or block trading
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

